MedWatch

Biden starts new offensive to bring down medicine prices

Novo and Lundbeck are dropping on the stock exchange as it is revealed that US President Joe Biden wants an extensive plan to fight high prices on prescription medicine in place within the next 45 days.

Photo: SAUL LOEB/AFP / AFP

US President Joe Biden issued an order on Friday criticizing the high prices of prescription medicine in the US, which according to the president are more than 2.5 times higher than in other countries - if not more.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Related articles

Latest news

See all jobs